Share this @internewscast.com

WASHINGTON — The Supreme Court on Wednesday took up a high-stakes legal battle that could lead to a definitive decision on whether the drug most commonly used for medication abortions will continue to be easily available, including by mail.

The court agreed to weigh appeals from the Biden administration and drugmaker Danco defending several Food and Drug Administration decisions that made it easier to access and use the mifepristone pill. Danco makes the brand version of the pill, Mifeprex.

The justices will hear oral arguments early next year, with a ruling due by the end of June.

The Biden administration welcomed the court’s intervention, with White House Press Secretary Karine Jean-Pierre saying in a statement that the lower court ruling under review “threatens to undermine the FDA’s scientific independent judgment and would reimpose outdated restrictions on access to safe and effective abortion medication.”

Danco said in a statement that it remains confident in the “safety and effectiveness” of the Mifeprex, which will stay available as normal under the current FDA rules while the Supreme Court hears the case.

“The FDA actions at issue were well supported by extensive safety and effectiveness data from clinical trials and decades worth of real-world experience in millions of patients,” the company’s statement added.

The legal challenge was brought by doctors and other medical professionals represented by the conservative Christian legal group Alliance Defending Freedom.

“Every court so far has agreed that the FDA acted unlawfully in removing common-sense safeguards for women and authorizing dangerous mail-order abortions,” said Erin Hawley, one of the group’s lawyers. “We urge the Supreme Court to do the same.”

The court, which has a 6-3 conservative majority, has previously shown hostility to abortion rights, overturning the landmark abortion rights ruling Roe v. Wade last year. But in April, in an earlier stage of the litigation, the court blocked a judge’s ruling that would have completely invalidated the FDA’s approval of the drug.

The abortion pill dispute does not directly address any right to abortion, focusing instead on different legal issues about the FDA’s process for approving drugs, but the case raised questions over the court’s pledge last year to leave abortion policy to the states and the federal government.

The FDA’s original decision in 2000 to approve the drug is not at issue in the Supreme Court, with the court turning away a separate appeal raising that issue.

The court will instead focus on later FDA actions from 2016 onward that made it easier to access the pill, including the initial 2021 decision that made it available by mail, which was finalized earlier this year.

Also under review are the 2016 decisions to extend the window in which mifepristone could be used to terminate pregnancies from seven weeks’ gestation to 10 weeks and reduce the number of in-person visits for patients from three to one. In another 2016 move, the FDA altered the dosing regimen, finding that a lower dose of mifepristone was sufficient.

Another way the court could dispose of the case would be to conclude that the challengers do not have legal standing to bring their lawsuit.

In 2019, the FDA approved a generic form of the drug, which is made by GenBioPro, although that issue is not at issue at the Supreme Court.

The New Orleans-based 5th U.S. Circuit Court of Appeals in August ruled that the post-2016 FDA decisions should be put on hold because the moves “were taken without sufficient consideration of the effects those changes would have on patients.” The court ruled against the challengers on their efforts to overturn the original approval of the drug and the later decision to authorize the generic version.

Both sides then filed appeals at the Supreme Court.

The current fight over the drug dates to a November 2022 lawsuit filed by the challengers. They claim that the FDA’s 2000 approval was flawed, as were later decisions that made the drug easier to access, in part because they failed to take into account safety risks to women. 

In a sweeping decision, Texas-based U.S. District Judge Matthew Kacsmaryk in April invalidated the FDA’s original approval of the drug from more than 20 years ago. After the Supreme Court put that decision on hold while litigation continued, the appeals court narrowed the scope of Kacsmaryk’s ruling, focusing on the post-2016 changes.

The FDA-approved regimen for a medication abortion involves two drugs: mifepristone, which blocks the hormone progesterone, and misoprostol, which induces contractions. A majority of abortions in the U.S. are carried out using the pills, according to a survey conducted by the Guttmacher Institute, a research group that supports abortion rights.

Access to medication abortion, especially by mail, has become of major importance in light of the Supreme Court ruling that overturned Roe v. Wade, which has led to conservative states enacting tough restrictions that either limit or ban abortion outright. Fourteen states currently have total abortion bans, according to Guttmacher.

Share this @internewscast.com
You May Also Like
Trump and George Soros have this in common: Scott Bessent

Scott Bessent Highlights a Commonality Between Trump and George Soros

President Trump and left-wing billionaire George Soros have more similarities than previously…
Trump wants mass deportations, but US views of immigration are more positive since he took office

Trump Advocates for Mass Deportations, Yet American Opinions on Immigration Have Grown More Favorable Since His Presidency

WASHINGTON (AP) — Mere months after President Donald Trump’s return to office…
Helicopter dropping cash from the sky.

Chaotic Scene Unfolds as Deceased Man’s Life Savings are Released from Helicopter, Leading to Frenzied Cash Grab

THIS is the moment a dead man’s life savings are dropped from…

Grandpa’s Last Seen Moments on Video: Wife Shares Concern Over His ‘Confused’ Departure

GAS station footage has revealed the last moments a doting grandfather was…
Parents crashing honeymoons becomes bizarre new travel trend

Unexpected Trend: Parents Tagging Along on Honeymoon Trips

Traditionally, a honeymoon serves as a unique getaway for newlyweds to relax…
Judge considers Abrego Garcia request to try to avoid deportation before trial

Judge Reviews Abrego Garcia’s Request to Prevent Deportation Prior to Trial

Abrego Garcia became a focal point concerning President Trump’s immigration policies when…
Chicago's 27th Ward Alderman Walter Burnett Jr. wants son to replace him in City Council after retirement, drawing criticism

Chicago Alderman Walter Burnett Jr. faces backlash for proposing his son as successor in City Council’s 27th Ward after retirement

The longest-tenured member of the Chicago City Council is stepping down at…
Driver arrested after attempting to drive through fence at US military base: authorities

Authorities Detain Driver for Trying to Break Through Fence at US Military Base

Officials in Virginia said an unauthorized individual attempted to enter Joint Base…
Flood recovery in San Marco faster with new pump station

Rapid Flood Recovery in San Marco Boosted by New Pump Station

A city spokesperson says many streets flooded in Wednesday’s deluge drained in…
Singer Chris Brown pleads not guilty to 2 further charges over London nightclub assault case

Chris Brown Maintains Innocence Against Additional London Nightclub Assault Charges

LONDON — Grammy-winning singer Chris Brown on Friday entered a not guilty…
Admiral Kuznetsov aircraft carrier in the English Channel.

Russia’s Sole Ailing Aircraft Carrier, Once Struggling Through the Channel, Set to Be Retired

VLADIMIR Putin’s only rustbucket aircraft carrier that struggled through the Channel is…
Friends who discovered Idaho murder victims reveal eerie omen before the massacre

Mother of Idaho murder victim finds surprising solace in controversial plea deal by the killer

The mother of University of Idaho victim Xana Kernodle has broken her…